Clinical trial
Clinical Study on the Effectiveness of Antibiotics Combined With Bifidobacterium Quadruple Live Tablets in Treating Cirrhosis With Spontaneous Bacterial Peritonitis and Preventing Recurrence-a Randomized, Double-blind, Placebo-controlled Multicenter Clinical Study
NCT07686861 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study on the Effectiveness of Antibiotics Combined With Bifidobacterium Quadruple Live Tablets in Treating Cirrhosis With Spontaneous Bacterial Peritonitis and Preventing Recurrence-a Randomized, Double-blind, Placebo-controlled Multicenter Clinical Study
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- February 28, 2028
- Enrollment
- 360 (estimated)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis with spontaneous bacterial peritonitis